Previous 10 | Next 10 |
The Nasdaq Composite closed above 11,000 for the first time signaling possible overvaluation. Here are three stocks with low P/Es in the index: Sprouts Farmers Market (SFM), United Therapeutics (UTHR), and Virtu Financial (VIRT). Last Thursday, the Nasdaq Composite closed above 11,000 for t...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Aug. 5, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Martine Rothblatt , Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the co...
Image source: The Motley Fool. United Therapeutics Corp (NASDAQ: UTHR) Q2 2020 Earnings Call Jul 29, 2020 , 9:00 a.m. ET Operator Continue reading
United Therapeutics Corporation (UTHR) Q2 2020 Earnings Conference Call July 29, 2020 9:00 am ET Corporate Participants Dewey Steadman - Head, Investor Relations Martine Rothblatt - Chairman and Chief Operating Officer Mike Benkowitz - President and Chief Operating Officer Leig...
United Therapeutics (NASDAQ: UTHR ) : Q2 Non-GAAP EPS of $3.68 beats by $0.41 ; GAAP EPS of $2.41 misses by $0.38 . More news on: United Therapeutics Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , July 29, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended June 30, 2020. "I am pleased with our performance during the second quarter, and ...
United Therapeutics (NASDAQ: UTHR ) has filed litigation in a Delaware court against Liquidia Technologies (NASDAQ: LQDA ) in response to the latter's U.S. marketing application seeking approval of LIQ861, a dry powder inhalation formulation of treprostinil. More news on: United Ther...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , July 23, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today the United States Patent and Trademark Office issued a new patent on July 21, 2020 , relating to Tyvaso ® (treprostinil) Inhalat...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , July 22, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its second quarter 2020 financial results before the market opens on Wednesday, July 29, 2020 . United Therapeut...
This article series has been releasing every month since 2015 a dashboard with aggregate industry metrics in healthcare (most popular ETFs in this sector: XLV , IYH , IBB , XBI , VHT , XPH ). Shortcut If you are used to this dashboard series or if you are short of time, you can s...
News, Short Squeeze, Breakout and More Instantly...
United Therapeutics Corporation Company Name:
UTHR Stock Symbol:
NASDAQ Market:
United Therapeutics Corporation Website:
A look at the top 10 most actives in the United States Aptevo Therapeutics Inc. (APVO) rose 45.1% to $0.486 on volume of 64,992,551 shares Verb Technology Company Inc. (VERB) rose 3.5% to $0.1205 on volume of 54,410,242 shares NVIDIA Corporation (NVDA) fell 4.4% to $120.752 on volume of 4...
2024-07-11 06:30:06 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for UTHR on July 11, 2024 04:53AM ET. The previous analyst recommendation was Overweight. UTHR was trading at $329.25 at issue of the analyst recommendation. The overall analyst consensus : ...
Over 100,000 patients in the United States have IPF, with two approved therapies available that only slow the course of disease progression Top line data expected in the second half of 2025 United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announ...